Search
mangafodipir (Teslascan)
Indications:
- contrast agent of magnetic resonance imaging of liver or pancreatic lesions
Dosage:
- 0.5 ml/kg bodyweight (5 umol/kg bodyweight) [1]
Injection: 0.01 mmol/ml solution for infusion, 7.57 mg/mL
Pharmacokinetics:
- near maximal enhancement of the normal liver & pancreas parenchyma is generally observed 15-20 minutes from the start of administration and lasts for approximately 4 hours
Interactions
drug adverse effects of contrast agents
General
contrast agent
References
- RxList
http://www.rxlist.com/teslascan-drug.htm